Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
2001 ◽
Vol 50
(4)
◽
pp. 191-198
◽
2001 ◽
Vol 10
(3)
◽
pp. 369-383
◽
Keyword(s):
2004 ◽
Vol 284
(1-2)
◽
pp. 133-140
◽
Keyword(s):
2001 ◽
Vol 10
(4)
◽
pp. 535-544
◽
Keyword(s):
2005 ◽
Vol 296
(1-2)
◽
pp. 31-36
◽
Keyword(s):